Prescribing of pancreatic enzyme therapy for malabsorption in unresectable pancreatic cancer: Cross-sectional survey across New Zealand and Australia
This study suggests clinicians are over-reliant on faecal elastase to diagnose PEI and are uncertain about the correct dose and timing of PERT for optimal patient benefit in those with unresectable pancreatic cancer. Most clinicians were not aware of best practice guidelines.
Authors
- Helen Brown (ORCID: https://orcid.org/0000-0002-1095-5148)
- FengFu Fu (ORCID: https://orcid.org/0000-0002-8823-7672)
- Vanessa Yenson (ORCID: https://orcid.org/0000-0002-7112-0785)
- Niamh Fanning (ORCID: https://orcid.org/0000-0003-4473-6063)
- John A. Windsor (ORCID: https://orcid.org/0000-0001-5995-5432)
- Kylie Russell (ORCID: https://orcid.org/0000-0001-9737-8533)
- Kate Clarke
- Clare McKenzie (ORCID: https://orcid.org/0000-0001-7682-3335)
- Meera Agar (ORCID: https://orcid.org/0000-0002-6756-6119)
- Amanda Landers (ORCID: https://orcid.org/0000-0002-7385-3739)
Institutions
- University of Technology Sydney (AU)
- University of Auckland (NZ)
- Nurse Maude Association (NZ)
- Tea Research Institute (CN)
- University of Otago (NZ)
Publication Details
- Journal
- Pancreatology
- Published
- 2024-10-13
- DOI
- https://doi.org/10.1016/j.pan.2024.10.008
- Citations
- 1
- Primary Topic
- Digestive system and related health
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- University of Auckland
- Canterbury District Health Board